4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide has been researched along with bezafibrate in 1 studies
| Studies (4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide) | Trials (4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide) | Recent Studies (post-2010) (4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide) | Studies (bezafibrate) | Trials (bezafibrate) | Recent Studies (post-2010) (bezafibrate) |
|---|---|---|---|---|---|
| 62 | 0 | 14 | 1,335 | 267 | 324 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mutoh, M; Niho, N; Wakabayashi, K | 1 |
1 review(s) available for 4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide and bezafibrate
| Article | Year |
|---|---|
Concomitant suppression of hyperlipidemia and intestinal polyp formation by increasing lipoprotein lipase activity in Apc-deficient mice.
Topics: Age Factors; Animals; Benzamides; Bezafibrate; Cyclooxygenase 2; Genes, APC; Humans; Hyperlipidemias; Intestinal Polyps; Lipoprotein Lipase; Membrane Proteins; Mice; Organophosphorus Compounds; Pioglitazone; PPAR alpha; PPAR gamma; Thiazolidinediones; Triglycerides | 2006 |